跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 356 条关于
“ACRI”
全部
356
临床试验
198
药物
69
机构
10
资讯
79
去年
NIH Awards $2.9 Million to ACRI for Cystic Fibrosis Therapy Research
去年
MedPacto's Vactosertib Achieves Complete Remission in Osteosarcoma Phase 2 Trial
2年前
Acrivon Therapeutics' ACR-368 Shows Promise in Endometrial Cancer; ACR-2316 Cleared for Phase 1 Trials
2年前
Acrivon's ACR-368 Shows Promise in Endometrial Cancer, ACR-2316 Advances to Clinic
去年
Acrivon Therapeutics Initiates Phase 1 Trial of WEE1/PKMYT1 Inhibitor ACR-2316 for Solid Tumors
去年
Acrivon Therapeutics to Showcase AP3 Platform and Clinical Program Updates at Upcoming R&D Event
去年
Caris Life Sciences and ECOG-ACRIN Partner to Enhance Breast Cancer Risk Stratification
去年
Acrivon Therapeutics Grants Equity Awards to Employees Under Nasdaq Rule 5635(c)(4)
去年
Acrivon Therapeutics Appoints Renowned Oncologist Dr. Mansoor Raza Mirza as Chief Medical Officer to Lead Clinical Development
3个月前
Acrivon Therapeutics Reports 44% Response Rate for CHK1/2 Inhibitor ACR-368 in Endometrial Cancer Phase II Trial
第 1 页,共 8 页
上一页
下一页